Targeting the De Novo Purine Synthesis Pathway Through Adenylosuccinate Lyase Depletion Impairs Liver Cancer Growth by Perturbing Mitochondrial Function
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is among the most common cancer types worldwide, yet patients with HCC have limited treatment options. There is an urgent need to identify drug targets that specifically inhibit the growth of HCC cells. APPROACH AND RESULTS: We used a CRISPR librar...
Main Authors: | Jiang, Tingting, Sánchez-Rivera, Francisco J, Soto-Feliciano, Yadira M, Yang, Qiyuan, Song, Chun-Qing, Bhuatkar, Arjun, Haynes, Cole M, Hemann, Michael T, Xue, Wen |
---|---|
Other Authors: | Whitehead Institute for Biomedical Research |
Format: | Article |
Language: | English |
Published: |
Wiley
2022
|
Online Access: | https://hdl.handle.net/1721.1/143563 |
Similar Items
-
Adenylosuccinate lyase deficiency in a Malaysian patient, with novel adenylosuccinate lyase gene mutations
by: Chen, B.C., et al.
Published: (2010) -
PHF6 is a novel regulator of B-cell identity in acute lymphoblastic leukemia
by: Soto-Feliciano, Yadira M. (Yadira Marie)
Published: (2016) -
Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration
by: Sánchez-Rivera, Francisco J, et al.
Published: (2021) -
Mechanistic studies on de novo purine biosynthesis : probing for intermediates of AIR synthetase, FGAR amidotransferase and AIR carboxylase
by: Mueller, Ernest James
Published: (2005) -
Excretion of purine derivatives in cows: endogenous contribution and recovery of exogenous purine bases
by: Boero, P. Orellana, et al.
Published: (2001)